Dear Colleague, Dietary Supplements Community:
This letter is to alert you that the Food and Drug Administration
(FDA) will be holding a
public meeting on April 4, 2000, to solicit input on two topics
pertaining to health claims in dietary supplement labeling.
One topic concerns implementation of the recent court of appeals
decision in Pearson v. Shalala (Pearson).
The second topic is whether claims about an effect on an existing
disease may be made a health claim, or
whether such claims should subject the product to regulation as a
drug. We are holding this meeting
to give the public an opportunity to provide information and views
on these topics.
A Federal Register notice detailing the specific issues, logistics,
and registration information will be published shortly.
|
Sincerely yours,
Christine J. Lewis, Ph.D. |
This document was issued on March 3, 2000.
For more recent information on Dietary Supplements
See
http://www.cfsan.fda.gov/~dms/supplmnt.html
Hypertext updated by dms/kwg 2000-NOV-27